References
Krumpl G, Ulc I, Trebs M, Kadlecova P, Hodisch J (2017) Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group. Eur J Clin Pharmacol 73(4):417–428. https://doi.org/10.1007/s00228-016-2176-0
Nasrollahi-Shirazi S, Sucic S, Yang Q, Freissmuth M, Nanoff C (2016) Comparison of the beta-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions. J Pharmacol Exp Ther 359(1):73–81. https://doi.org/10.1124/jpet.116.232884
Shibata S, Okamoto Y, Endo S, Ono K (2012) Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts. J Pharmacol Sci 118(2):255–265
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Rights and permissions
About this article
Cite this article
Frank, G., Fitzgerald, R.D. Advantage of landiolol over esmolol? We doubt it!. Eur J Clin Pharmacol 74, 671–672 (2018). https://doi.org/10.1007/s00228-017-2408-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-017-2408-y